[Federal Register Volume 80, Number 50 (Monday, March 16, 2015)]
[Notices]
[Page 13576]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-05827]



[[Page 13576]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Sustained Release for 
Antiretroviral Treatment of Prevention (SRATP) of HIV Infection 
(UM1).
    Date: April 6-7, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Room LD30A & LD30B, 5601 
Fishers Lane, Rockville, MD 20892.
    Contact Person: Jay Bruce Sundstrom, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, Room 3G11A, National Institutes of Health/NIAID, 5601 
Fishers Lane, MSC 9823, Rockville, MD 20892, 240-669-5045, 
<a href="/cdn-cgi/l/email-protection#1c6f6972786f686e7371765c72757d757832727574327b736a"><span class="__cf_email__" data-cfemail="cebdbba0aabdbabca1a3a48ea0a7afa7aae0a0a7a6e0a9a1b8">[email protected]</span></a>.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; ``NIAID SBIR Phase II Clinical 
Trial Implementation Cooperative Agreement (U44)''.
    Date: April 15, 2015.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Room 3G61, 5601 Fishers 
Lane, Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Travis J. Taylor, Ph.D., Scientific Review 
Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, Rockville, MD 20892, 
240-669-5082, <a href="/cdn-cgi/l/email-protection#7e2a0c1f08170d502a1f0712110c3e10171650191108"><span class="__cf_email__" data-cfemail="d286a0b3a4bba1fc86b3abbebda092bcbbbafcb5bda4">[email protected]</span></a>.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel NIAID; Investigator Initiated 
Program Project Applications (P01).
    Date: April 28, 2015.
    Time: 12:30 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Dharmendar Rathore, Ph.D., Senior Scientific 
Review Officer, Scientific Review Program, Division of Extramural 
Activities, National Institutes of Health/NIAID, 5601 Fishers Lane, 
Rockville, MD 20892, 240-669-5058, <a href="/cdn-cgi/l/email-protection#e0928194888f928584a08d81898cce8e8988ce878f96"><span class="__cf_email__" data-cfemail="71031005191e031415311c10181d5f1f18195f161e07">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: March 10, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-05827 Filed 3-13-15; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>